PAGNAN, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.005
EU - Europa 459
AS - Asia 414
OC - Oceania 2
Totale 4.880
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.000
CN - Cina 218
SG - Singapore 126
DE - Germania 110
FI - Finlandia 84
SE - Svezia 66
VN - Vietnam 62
UA - Ucraina 60
GB - Regno Unito 48
IT - Italia 36
FR - Francia 28
IE - Irlanda 9
NL - Olanda 7
CA - Canada 5
PH - Filippine 3
BE - Belgio 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
IN - India 2
NZ - Nuova Zelanda 2
RO - Romania 2
TR - Turchia 2
AT - Austria 1
AZ - Azerbaigian 1
ES - Italia 1
HU - Ungheria 1
Totale 4.880
Salva come PNG Salva come JPEG
Città #
Fairfield 664
Chandler 339
Houston 324
Woodbridge 323
Jacksonville 295
Ashburn 271
Seattle 256
Cambridge 241
Wilmington 224
Ann Arbor 209
Princeton 124
Singapore 94
Boardman 85
Beijing 62
Dong Ket 62
San Diego 57
Roxbury 45
Nanjing 39
Santa Clara 31
Des Moines 27
Helsinki 22
London 16
Jiaxing 11
Washington 10
Changsha 9
Hebei 9
Norwalk 9
Dublin 8
Medford 8
Redwood City 8
Shenyang 8
Nanchang 7
Nürnberg 7
Falls Church 6
Guangzhou 5
Milan 5
Padova 5
Indiana 4
New York 4
Borås 3
Kharkiv 3
Rockville 3
Tianjin 3
Chicago 2
Dallas 2
Florence 2
Horia 2
Istanbul 2
Los Angeles 2
Ningbo 2
Ogden 2
Prescot 2
Pune 2
Shanghai 2
Sofia 2
Waanrode 2
Auckland 1
Baku 1
Bologna 1
Budapest 1
Dearborn 1
Forest City 1
Frankfurt am Main 1
Geislingen an der Steige 1
Grammichele 1
Haikou 1
Halethorpe 1
Hefei 1
Hounslow 1
Huzhou 1
Jinan 1
Kanata 1
Kiev 1
Lanzhou 1
Madrid 1
Munich 1
New Bedfont 1
Orange 1
Pinehaven 1
Portlaoise 1
Salerno 1
San Francisco 1
Segrate 1
Selargius 1
Shenzhen 1
Simi Valley 1
Southwark 1
Stockholm 1
Suresnes 1
Toronto 1
Tortona 1
Trento 1
Winnipeg 1
Wolverhampton 1
Yellow Springs 1
Totale 4.010
Salva come PNG Salva come JPEG
Nome #
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 171
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score 152
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor 140
Acute oppressive chest pain in a 66-year-old woman with a recent Amplatzer device closure of patent foramen ovale 129
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 121
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 117
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 109
Identifying type Vicenza von Willebrand disease 106
ARE HODGKIN AND NON HODGKIN PATIENTS TO A GREATER RISK OF ATHEROSCLEROSIS? A FOLLOW UP OF 3YEARS 105
von Willebrand factor abnormalities in aortic valve stenosis:pathophysiology and impact on bleeding. 105
Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. 101
The natural history of hypertension in turkeys. 99
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 98
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 98
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 95
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 94
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 91
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 89
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 89
Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts 88
Comparison of methods for determination ofglomerular filtration rate in hypertensive subjects with normal serum creatinine 86
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 85
Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome 83
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 82
Local photodynamic therapy with Zn(II)-phthalocyanine in an experimental model of intimal hyperplasia 82
THE LONG TERM CLINICAL COURSE OF ACUTE DEEP VEIN THROMBOSIS OF THE ARM: PROSPECTIVE COHORT STUDY 81
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. 81
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. 80
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 80
Inactivation of vascular smooth muscle cells photosensitised by liposome-delivered Zn(II)-phthalocyanine 79
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 78
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial 77
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients 76
Cerebral venous thrombosis as rare onset of Churg-Strauss syndrome 75
Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys236Phe mutation in the B2 domain 73
Time course of apoptosis and proliferation in vascular smooth muscle cells after balloon angioplasty 71
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation 71
The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns 70
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 69
Endothelial dysfunction in haemophilia patients. 69
The value of 64-detector row computed tomography for the exclusion of pulmonary embolism 67
Therapeutic, hemodynamic, and metabolic effects of hyperbaric oxygenation in peripheral vascular disease. 67
Recurrent thromboembolism in cancer patients: incidence and risk factors. 67
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 64
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis 60
Therapeutic indications for acute venous thromboembolism. Current status and future perspectives 56
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism 56
Postthrombotic syndrome 56
Role of PAI-1 in the differential diagnosis of hepatic veno-occlusive disease complicating hematopoietic stem cell transplantation: study in a pediatric population 54
An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia 54
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 53
An apparent silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease. 49
Serum lipoproteins and atherosclerosis in hypertensive broad breasted white turkeys. 49
Evidence of reduced atherosclerotic lesions in broad breasted white turkeys treated with oxprenolol. 48
Evidence of postprandial absorption of olive oil phenols in humans. 47
Cardiovascular risk factors and ultrasound evaluation of intima media thickness at common carotids, carotid bulbs, femoral and abdominal aorta arteries in patients with classic Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency. 47
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 47
Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population 47
[Feasibility of a program of moderate restriction of sodium using salt with low contents of sodium and dietetic prescriptions]. 45
Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis Findings from a cross-sectional survey 45
Apoptosi e ristenosi 40
The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S 28
Totale 4.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.832
article - articoli 17.637
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020738 0 0 0 0 105 92 91 123 113 107 51 56
2020/2021842 26 56 60 75 65 119 16 77 123 55 89 81
2021/2022809 27 98 98 50 34 51 32 94 39 9 121 156
2022/2023658 130 83 7 68 109 98 0 42 81 3 31 6
2023/2024311 14 67 42 24 34 26 19 12 9 6 31 27
2024/2025329 0 81 63 70 115 0 0 0 0 0 0 0
Totale 4.891